Use of IL-23 or IL-23R Antagonists to Treat Uveitis Read more about Use of IL-23 or IL-23R Antagonists to Treat Uveitis US Application 60/713,792Filed on 2005-09-01
The Use Of High Dose Anti-IL2 Receptor Antibody To Treat Acutely Active Sight Threatening Non Infectious Uveitis Read more about The Use Of High Dose Anti-IL2 Receptor Antibody To Treat Acutely Active Sight Threatening Non Infectious Uveitis US Application 60/616,760Filed on 2004-10-06
Formulation Of Triamcinolone Acetonide Suspension For Intravitreal Delivery By Injection Read more about Formulation Of Triamcinolone Acetonide Suspension For Intravitreal Delivery By Injection US Application 60/628,741Filed on 2004-11-17
PEDF-R Receptor and Uses Read more about PEDF-R Receptor and Uses US Application 60/579,177Filed on 2004-06-12
PEDF-R Receptor and Uses Read more about PEDF-R Receptor and Uses US Application 60/493,713Filed on 2003-08-07
TRANSKETOLASE AS A THERAPEUTIC AND DIAGNOSTIC TARGET Read more about TRANSKETOLASE AS A THERAPEUTIC AND DIAGNOSTIC TARGET US Application 60/402,365Filed on 2002-08-08
Conversion of Naturally-Occurring Quinones to Quinone Derivatives by Macrophage Migration Inhibiton Factor and Uses Thereof. Read more about Conversion of Naturally-Occurring Quinones to Quinone Derivatives by Macrophage Migration Inhibiton Factor and Uses Thereof. US Application 60/094,246Filed on 1998-07-27
ANIMAL MODEL FOR AGE-RELATED MACULAR DEGENERATION AND METHODS FOR USE THEREOF Read more about ANIMAL MODEL FOR AGE-RELATED MACULAR DEGENERATION AND METHODS FOR USE THEREOF US Application 60/060,045Filed on 1997-09-25
NOVEL RECEPTOR FOR PIGMENT EPITHELIUM-DERIVED FACTOR Read more about NOVEL RECEPTOR FOR PIGMENT EPITHELIUM-DERIVED FACTOR US Application 60/015,304Filed on 1996-04-12
HYDROXYLAMINE COMPOSITIONS FOR THE PREVENTION OR RETARDATION OF CATARACTS Read more about HYDROXYLAMINE COMPOSITIONS FOR THE PREVENTION OR RETARDATION OF CATARACTS US Application 60/010,637Filed on 1996-01-26